000			02216 a2200625 4500
005			20250513130405.0
264		0	_c19971119
008			199711s 0 0 eng d
022			_a0277-3732
024	7		_a10.1097/00000421-199710000-00019 _2doi
040			_aNLM _beng _cNLM
100	1		_aColozza, M
245	0	0	_aLong-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide. _h[electronic resource]
260			_bAmerican journal of clinical oncology _cOct 1997
300			_a522-6 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnalysis of Variance
650	0	4	_aAntibiotics, Antineoplastic _xadministration & dosage
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Agents, Alkylating _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aAscites _xpathology
650	0	4	_aCarcinoma _xdrug therapy
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aConfidence Intervals
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aForecasting
650	0	4	_aHumans
650	0	4	_aLaparotomy
650	0	4	_aLongitudinal Studies
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aNeoplasm Staging
650	0	4	_aNeoplasm, Residual
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aPrognosis
650	0	4	_aRemission Induction
650	0	4	_aReoperation
650	0	4	_aSurvival Rate
700	1		_aMosconi, A M
700	1		_aGori, S
700	1		_aBelsanti, V
700	1		_aBasurto, C
700	1		_aDe Angelis, V
700	1		_aGiansanti, M
700	1		_aTonato, M
773	0		_tAmerican journal of clinical oncology _gvol. 20 _gno. 5 _gp. 522-6
856	4	0	_uhttps://doi.org/10.1097/00000421-199710000-00019 _zAvailable from publisher's website
999			_c9316314 _d9316314